+1 (704) 266-3234

Global Choroidal Neovascularization Drug Market Insights, Forecast To 2025

Published on: Mar 2019 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 127

The global Choroidal Neovascularization Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Choroidal Neovascularization Drug market based on company, product type, end user and key regions.



This report studies the global market size of Choroidal Neovascularization Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Choroidal Neovascularization Drug in these regions.

This research report categorizes the global Choroidal Neovascularization Drug market by top players/brands, region, type and end user. This report also studies the global Choroidal Neovascularization Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.



The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Cellphire, Inc.

Chrysalis BioTherapeutics, Inc.

Cleveland BioLabs, Inc.

Cumberland Pharmaceuticals, Inc.

Diffusion Pharmaceuticals Inc.

Eli Lilly and Company

GNI Group Ltd.

Humanetics Corporation

INSYS Therapeutics, Inc.

Meabco A/S

Neumedicines Inc.

Onconova Therapeutics, Inc.

PharmaIN Corporation

Pluristem Therapeutics Inc.

ProCertus BioPharm Inc.

RDD Pharma Ltd.

RedHill Biopharma Ltd.

RxBio, Inc.

Soligenix, Inc.



Market size by Product

AVMOC-001

BB-3

BBT-007

DG-3

Entolimod

EWA-001

Others

Market size by End User

Clinic

Hospital

Others



Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa



The study objectives of this report are:

To study and analyze the global Choroidal Neovascularization Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Choroidal Neovascularization Drug market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Choroidal Neovascularization Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Choroidal Neovascularization Drug submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.



In this study, the years considered to estimate the market size of Choroidal Neovascularization Drug are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025



This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Choroidal Neovascularization Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.



For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents



1 Study Coverage

1.1 Choroidal Neovascularization Drug Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Choroidal Neovascularization Drug Market Size Growth Rate by Product

1.4.2 AVMOC-001

1.4.3 BB-3

1.4.4 BBT-007

1.4.5 DG-3

1.4.6 Entolimod

1.4.7 EWA-001

1.4.8 Others

1.5 Market by End User

1.5.1 Global Choroidal Neovascularization Drug Market Size Growth Rate by End User

1.5.2 Clinic

1.5.3 Hospital

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered



2 Executive Summary

2.1 Global Choroidal Neovascularization Drug Market Size

2.1.1 Global Choroidal Neovascularization Drug Revenue 2014-2025

2.1.2 Global Choroidal Neovascularization Drug Sales 2014-2025

2.2 Choroidal Neovascularization Drug Growth Rate by Regions

2.2.1 Global Choroidal Neovascularization Drug Sales by Regions

2.2.2 Global Choroidal Neovascularization Drug Revenue by Regions



3 Breakdown Data by Manufacturers

3.1 Choroidal Neovascularization Drug Sales by Manufacturers

3.1.1 Choroidal Neovascularization Drug Sales by Manufacturers

3.1.2 Choroidal Neovascularization Drug Sales Market Share by Manufacturers

3.1.3 Global Choroidal Neovascularization Drug Market Concentration Ratio (CR5 and HHI)

3.2 Choroidal Neovascularization Drug Revenue by Manufacturers

3.2.1 Choroidal Neovascularization Drug Revenue by Manufacturers (2014-2019)

3.2.2 Choroidal Neovascularization Drug Revenue Share by Manufacturers (2014-2019)

3.3 Choroidal Neovascularization Drug Price by Manufacturers

3.4 Choroidal Neovascularization Drug Manufacturing Base Distribution, Product Types

3.4.1 Choroidal Neovascularization Drug Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Choroidal Neovascularization Drug Product Type

3.4.3 Date of International Manufacturers Enter into Choroidal Neovascularization Drug Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans



4 Breakdown Data by Product

4.1 Global Choroidal Neovascularization Drug Sales by Product

4.2 Global Choroidal Neovascularization Drug Revenue by Product

4.3 Choroidal Neovascularization Drug Price by Product



5 Breakdown Data by End User

5.1 Overview

5.2 Global Choroidal Neovascularization Drug Breakdown Data by End User



6 North America

6.1 North America Choroidal Neovascularization Drug by Countries

6.1.1 North America Choroidal Neovascularization Drug Sales by Countries

6.1.2 North America Choroidal Neovascularization Drug Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Choroidal Neovascularization Drug by Product

6.3 North America Choroidal Neovascularization Drug by End User



7 Europe

7.1 Europe Choroidal Neovascularization Drug by Countries

7.1.1 Europe Choroidal Neovascularization Drug Sales by Countries

7.1.2 Europe Choroidal Neovascularization Drug Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Choroidal Neovascularization Drug by Product

7.3 Europe Choroidal Neovascularization Drug by End User



8 Asia Pacific

8.1 Asia Pacific Choroidal Neovascularization Drug by Countries

8.1.1 Asia Pacific Choroidal Neovascularization Drug Sales by Countries

8.1.2 Asia Pacific Choroidal Neovascularization Drug Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Choroidal Neovascularization Drug by Product

8.3 Asia Pacific Choroidal Neovascularization Drug by End User



9 Central & South America

9.1 Central & South America Choroidal Neovascularization Drug by Countries

9.1.1 Central & South America Choroidal Neovascularization Drug Sales by Countries

9.1.2 Central & South America Choroidal Neovascularization Drug Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Choroidal Neovascularization Drug by Product

9.3 Central & South America Choroidal Neovascularization Drug by End User



10 Middle East and Africa

10.1 Middle East and Africa Choroidal Neovascularization Drug by Countries

10.1.1 Middle East and Africa Choroidal Neovascularization Drug Sales by Countries

10.1.2 Middle East and Africa Choroidal Neovascularization Drug Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Choroidal Neovascularization Drug by Product

10.3 Middle East and Africa Choroidal Neovascularization Drug by End User



11 Company Profiles

11.1 Cellphire, Inc.

11.1.1 Cellphire, Inc. Company Details

11.1.2 Company Business Overview

11.1.3 Cellphire, Inc. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.1.4 Cellphire, Inc. Choroidal Neovascularization Drug Products Offered

11.1.5 Cellphire, Inc. Recent Development

11.2 Chrysalis BioTherapeutics, Inc.

11.2.1 Chrysalis BioTherapeutics, Inc. Company Details

11.2.2 Company Business Overview

11.2.3 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.2.4 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Products Offered

11.2.5 Chrysalis BioTherapeutics, Inc. Recent Development

11.3 Cleveland BioLabs, Inc.

11.3.1 Cleveland BioLabs, Inc. Company Details

11.3.2 Company Business Overview

11.3.3 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.3.4 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Products Offered

11.3.5 Cleveland BioLabs, Inc. Recent Development

11.4 Cumberland Pharmaceuticals, Inc.

11.4.1 Cumberland Pharmaceuticals, Inc. Company Details

11.4.2 Company Business Overview

11.4.3 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.4.4 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Products Offered

11.4.5 Cumberland Pharmaceuticals, Inc. Recent Development

11.5 Diffusion Pharmaceuticals Inc.

11.5.1 Diffusion Pharmaceuticals Inc. Company Details

11.5.2 Company Business Overview

11.5.3 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.5.4 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Products Offered

11.5.5 Diffusion Pharmaceuticals Inc. Recent Development

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Details

11.6.2 Company Business Overview

11.6.3 Eli Lilly and Company Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.6.4 Eli Lilly and Company Choroidal Neovascularization Drug Products Offered

11.6.5 Eli Lilly and Company Recent Development

11.7 GNI Group Ltd.

11.7.1 GNI Group Ltd. Company Details

11.7.2 Company Business Overview

11.7.3 GNI Group Ltd. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.7.4 GNI Group Ltd. Choroidal Neovascularization Drug Products Offered

11.7.5 GNI Group Ltd. Recent Development

11.8 Humanetics Corporation

11.8.1 Humanetics Corporation Company Details

11.8.2 Company Business Overview

11.8.3 Humanetics Corporation Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.8.4 Humanetics Corporation Choroidal Neovascularization Drug Products Offered

11.8.5 Humanetics Corporation Recent Development

11.9 INSYS Therapeutics, Inc.

11.9.1 INSYS Therapeutics, Inc. Company Details

11.9.2 Company Business Overview

11.9.3 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.9.4 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Products Offered

11.9.5 INSYS Therapeutics, Inc. Recent Development

11.10 Meabco A/S

11.10.1 Meabco A/S Company Details

11.10.2 Company Business Overview

11.10.3 Meabco A/S Choroidal Neovascularization Drug Sales, Revenue and Gross Margin (2014-2019)

11.10.4 Meabco A/S Choroidal Neovascularization Drug Products Offered

11.10.5 Meabco A/S Recent Development

11.11 Neumedicines Inc.

11.12 Onconova Therapeutics, Inc.

11.13 PharmaIN Corporation

11.14 Pluristem Therapeutics Inc.

11.15 ProCertus BioPharm Inc.

11.16 RDD Pharma Ltd.

11.17 RedHill Biopharma Ltd.

11.18 RxBio, Inc.

11.19 Soligenix, Inc.



12 Future Forecast

12.1 Choroidal Neovascularization Drug Market Forecast by Regions

12.1.1 Global Choroidal Neovascularization Drug Sales Forecast by Regions 2019-2025

12.1.2 Global Choroidal Neovascularization Drug Revenue Forecast by Regions 2019-2025

12.2 Choroidal Neovascularization Drug Market Forecast by Product

12.2.1 Global Choroidal Neovascularization Drug Sales Forecast by Product 2019-2025

12.2.2 Global Choroidal Neovascularization Drug Revenue Forecast by Product 2019-2025

12.3 Choroidal Neovascularization Drug Market Forecast by End User

12.4 North America Choroidal Neovascularization Drug Forecast

12.5 Europe Choroidal Neovascularization Drug Forecast

12.6 Asia Pacific Choroidal Neovascularization Drug Forecast

12.7 Central & South America Choroidal Neovascularization Drug Forecast

12.8 Middle East and Africa Choroidal Neovascularization Drug Forecast



13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators



14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Choroidal Neovascularization Drug Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors



15 Research Findings and Conclusion



16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures



Figure Choroidal Neovascularization Drug Product Picture

Table Choroidal Neovascularization Drug Market Segments

Table Key Manufacturers Choroidal Neovascularization Drug Covered

Table Global Choroidal Neovascularization Drug Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)

Figure Global Choroidal Neovascularization Drug Sales Market Share by Product 2014-2025

Figure AVMOC-001 Product Picture

Table Major Manufacturers of AVMOC-001

Figure BB-3 Product Picture

Table Major Manufacturers of BB-3

Figure BBT-007 Product Picture

Table Major Manufacturers of BBT-007

Figure DG-3 Product Picture

Table Major Manufacturers of DG-3

Figure Entolimod Product Picture

Table Major Manufacturers of Entolimod

Figure EWA-001 Product Picture

Table Major Manufacturers of EWA-001

Figure Others Product Picture

Table Major Manufacturers of Others

Table Global Choroidal Neovascularization Drug Market Size Growth Rate by End User 2019-2025 (K Pcs)

Figure Clinic

Figure Hospital

Figure Others

Figure Choroidal Neovascularization Drug Report Years Considered

Figure Global Choroidal Neovascularization Drug Market Size 2014-2025 (Million US$)

Figure Global Choroidal Neovascularization Drug Sales 2014-2025 (K Pcs)

Table Global Choroidal Neovascularization Drug Market Size by Regions 2014-2019 (K Pcs) & (Million US$)

Table Global Choroidal Neovascularization Drug Sales by Regions 2014-2019 (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Market Share by Regions 2014-2019

Figure Global Choroidal Neovascularization Drug Sales Market Share by Regions 2014-2019

Figure 2018 Global Choroidal Neovascularization Drug Sales Market Share by Regions

Table Global Choroidal Neovascularization Drug Revenue by Regions 2014-2019 (Million US$)

Table Global Choroidal Neovascularization Drug Revenue Market Share by Regions 2014-2019

Figure Global Choroidal Neovascularization Drug Revenue Market Share by Regions 2014-2019

Figure 2018 Global Choroidal Neovascularization Drug Revenue Market Share by Regions

Table Global Choroidal Neovascularization Drug Sales by Manufacturers (2014-2019) (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Share by Manufacturers (2014-2019)

Figure Global Choroidal Neovascularization Drug Sales Share by Manufacturers in 2018

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Choroidal Neovascularization Drug Revenue by Manufacturers (2014-2019) (Million USD)

Table Choroidal Neovascularization Drug Revenue Share by Manufacturers (2014-2019)

Figure Choroidal Neovascularization Drug Value Share by Manufacturers in 2018

Table Key Manufacturers Choroidal Neovascularization Drug Price (2014-2019) (USD/Pcs)

Table Choroidal Neovascularization Drug Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Choroidal Neovascularization Drug Product Type

Table Date of International Manufacturers Enter into Choroidal Neovascularization Drug Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Choroidal Neovascularization Drug Sales by Product (2014-2019) (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Share by Product (2014-2019)

Figure Global Choroidal Neovascularization Drug Sales Market Share by Product (2014-2019)

Figure Global Choroidal Neovascularization Drug Sales Market Share by Product in 2018

Table Global Choroidal Neovascularization Drug Revenue by Product (2014-2019) (Million US$)

Table Global Choroidal Neovascularization Drug Revenue Share by Product (2014-2019)

Figure Global Choroidal Neovascularization Drug Revenue Market Share by Product (2014-2019)

Figure Global Choroidal Neovascularization Drug Revenue Market Share by Product in 2018

Table Choroidal Neovascularization Drug Price by Product 2014-2019 (USD/Pcs)

Table Global Choroidal Neovascularization Drug Sales by End User (2014-2019) (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Share by End User (2014-2019)

Figure Global Sales Choroidal Neovascularization Drug Market Share by End User (2014-2019)

Figure Global Sales Choroidal Neovascularization Drug Market Share by End User in 2018

Figure North America Choroidal Neovascularization Drug Sales Growth Rate 2014-2019 (K Pcs)

Figure North America Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million US$)

Table North America Choroidal Neovascularization Drug Sales by Countries (2014-2019) (K Pcs)

Table North America Choroidal Neovascularization Drug Sales Market Share by Countries (2014-2019)

Figure 2018 North America Choroidal Neovascularization Drug Sales Market Share by Countries

Table North America Choroidal Neovascularization Drug Revenue by Countries (2014-2019) (Million US$)

Table North America Choroidal Neovascularization Drug Revenue Market Share by Countries (2014-2019)

Figure 2018 North America Choroidal Neovascularization Drug Revenue Market Share by Countries

Figure United States Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure United States Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (K Pcs)

Figure Canada Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Canada Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Mexico Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Mexico Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Table North America Choroidal Neovascularization Drug Sales by Product (2014-2019) (K Pcs)

Table North America Choroidal Neovascularization Drug Sales Market Share by Product (2014-2019)

Figure 2018 North America Choroidal Neovascularization Drug Market Share by Product

Table North America Choroidal Neovascularization Drug Sales by End User (2014-2019) (K Pcs)

Table North America Choroidal Neovascularization Drug Sales Market Share by End User (2014-2019)

Figure 2018 North America Choroidal Neovascularization Drug Market Share by End User

Figure Europe Choroidal Neovascularization Drug Sales Growth Rate 2014-2019 (K Pcs)

Figure Europe Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million US$)

Table Europe Choroidal Neovascularization Drug Sales by Countries (2014-2019) (K Pcs)

Table Europe Choroidal Neovascularization Drug Sales Market Share by Countries (2014-2019)

Figure 2018 Europe Choroidal Neovascularization Drug Sales Market Share by Countries

Table Europe Choroidal Neovascularization Drug Revenue by Countries (2014-2019) (Million US$)

Table Europe Choroidal Neovascularization Drug Revenue Market Share by Countries (2014-2019)

Figure 2018 Europe Choroidal Neovascularization Drug Revenue Market Share by Countries

Figure Germany Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Germany Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure France Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure France Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure UK Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure UK Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Italy Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Italy Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Russia Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Russia Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Table Europe Choroidal Neovascularization Drug Sales by Product (2014-2019) (K Pcs)

Table Europe Choroidal Neovascularization Drug Sales Market Share by Product (2014-2019)

Figure 2018 Europe Choroidal Neovascularization Drug Market Share by Product

Table Europe Choroidal Neovascularization Drug Sales by End User (2014-2019) (K Pcs)

Table Europe Choroidal Neovascularization Drug Sales Market Share by End User (2014-2019)

Figure 2018 Europe Choroidal Neovascularization Drug Market Share by End User

Figure Asia Pacific Choroidal Neovascularization Drug Sales Growth Rate 2014-2019 (K Pcs)

Figure Asia Pacific Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million US$)

Table Asia Pacific Choroidal Neovascularization Drug Sales by Countries (2014-2019) (K Pcs)

Table Asia Pacific Choroidal Neovascularization Drug Sales Market Share by Countries (2014-2019)

Figure 2018 Asia Pacific Choroidal Neovascularization Drug Sales Market Share by Countries

Table Asia Pacific Choroidal Neovascularization Drug Revenue by Countries (2014-2019) (Million US$)

Table Asia Pacific Choroidal Neovascularization Drug Revenue Market Share by Countries (2014-2019)

Figure 2018 Asia Pacific Choroidal Neovascularization Drug Revenue Market Share by Countries

Figure China Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure China Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Japan Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Japan Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Korea Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Korea Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure India Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure India Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Australia Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Australia Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Indonesia Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Indonesia Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Malaysia Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Malaysia Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Philippines Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Philippines Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Thailand Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Thailand Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Vietnam Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Vietnam Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Singapore Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Singapore Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Table Asia Pacific Choroidal Neovascularization Drug Sales by Product (2014-2019) (K Pcs)

Table Asia Pacific Choroidal Neovascularization Drug Sales Market Share by Product (2014-2019)

Figure 2018 Asia Pacific Choroidal Neovascularization Drug Market Share by Product

Table Asia Pacific Choroidal Neovascularization Drug Sales by End User (2014-2019) (K Pcs)

Table Asia Pacific Choroidal Neovascularization Drug Sales Market Share by End User (2014-2019)

Figure 2018 Asia Pacific Choroidal Neovascularization Drug Market Share by End User

Figure Central & South America Choroidal Neovascularization Drug Sales Growth Rate 2014-2019 (K Pcs)

Figure Central & South America Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million US$)

Table Central & South America Choroidal Neovascularization Drug Sales by Countries (2014-2019) (K Pcs)

Table Central & South America Choroidal Neovascularization Drug Sales Market Share by Countries (2014-2019)

Figure 2018 Central & South America Choroidal Neovascularization Drug Sales Market Share by Countries

Table Central & South America Choroidal Neovascularization Drug Revenue by Countries (2014-2019) (Million US$)

Table Central & South America Choroidal Neovascularization Drug Revenue Market Share by Countries (2014-2019)

Figure 2018 Central & South America Choroidal Neovascularization Drug Revenue Market Share by Countries

Figure Brazil Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Brazil Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Argentina Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Argentina Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Table Central & South America Choroidal Neovascularization Drug Sales by Product (2014-2019) (K Pcs)

Table Central & South America Choroidal Neovascularization Drug Sales Market Share by Product (2014-2019)

Figure 2018 Central & South America Choroidal Neovascularization Drug Market Share by Product

Table Central & South America Choroidal Neovascularization Drug Sales by End User (2014-2019) (K Pcs)

Table Central & South America Choroidal Neovascularization Drug Sales Market Share by End User (2014-2019)

Figure 2018 Central & South America Choroidal Neovascularization Drug Market Share by End User

Figure Middle East and Africa Choroidal Neovascularization Drug Sales Growth Rate 2014-2019 (K Pcs)

Figure Middle East and Africa Choroidal Neovascularization Drug Revenue Growth Rate 2014-2019 (Million US$)

Table Middle East and Africa Choroidal Neovascularization Drug Sales by Countries (2014-2019) (K Pcs)

Table Middle East and Africa Choroidal Neovascularization Drug Sales Market Share by Countries (2014-2019)

Figure 2018 Middle East and Africa Choroidal Neovascularization Drug Sales Market Share by Countries

Table Middle East and Africa Choroidal Neovascularization Drug Revenue by Countries (2014-2019) (Million US$)

Table Middle East and Africa Choroidal Neovascularization Drug Revenue Market Share by Countries (2014-2019)

Figure 2018 Middle East and Africa Choroidal Neovascularization Drug Revenue Market Share by Countries

Figure GCC Countries Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure GCC Countries Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Turkey Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Turkey Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure Egypt Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure Egypt Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Figure South Africa Choroidal Neovascularization Drug Sales Growth Rate (2014-2019) (K Pcs)

Figure South Africa Choroidal Neovascularization Drug Revenue Growth Rate (2014-2019) (Million US$)

Table Middle East and Africa Choroidal Neovascularization Drug Sales by Product (2014-2019) (K Pcs)

Table Middle East and Africa Choroidal Neovascularization Drug Sales Market Share by Product (2014-2019)

Figure 2018 Middle East and Africa Choroidal Neovascularization Drug Market Share by Product

Table Middle East and Africa Choroidal Neovascularization Drug Sales by End User (2014-2019) (K Pcs)

Table Middle East and Africa Choroidal Neovascularization Drug Sales Market Share by End User (2014-2019)

Figure 2018 Middle East and Africa Choroidal Neovascularization Drug Market Share by End User

Table Cellphire, Inc. Company Details

Table Cellphire, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Cellphire, Inc. Recent Development


Table Chrysalis BioTherapeutics, Inc. Company Details

Table Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Chrysalis BioTherapeutics, Inc. Recent Development


Table Cleveland BioLabs, Inc. Company Details

Table Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Cleveland BioLabs, Inc. Recent Development


Table Cumberland Pharmaceuticals, Inc. Company Details

Table Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Cumberland Pharmaceuticals, Inc. Recent Development


Table Diffusion Pharmaceuticals Inc. Company Details

Table Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Diffusion Pharmaceuticals Inc. Recent Development


Table Eli Lilly and Company Company Details

Table Eli Lilly and Company Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Eli Lilly and Company Recent Development


Table GNI Group Ltd. Company Details

Table GNI Group Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table GNI Group Ltd. Recent Development


Table Humanetics Corporation Company Details

Table Humanetics Corporation Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Humanetics Corporation Recent Development


Table INSYS Therapeutics, Inc. Company Details

Table INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table INSYS Therapeutics, Inc. Recent Development


Table Meabco A/S Company Details

Table Meabco A/S Choroidal Neovascularization Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)

Table Meabco A/S Recent Development


Table Neumedicines Inc. Company Details

Table Onconova Therapeutics, Inc. Company Details

Table PharmaIN Corporation Company Details

Table Pluristem Therapeutics Inc. Company Details

Table ProCertus BioPharm Inc. Company Details

Table RDD Pharma Ltd. Company Details

Table RedHill Biopharma Ltd. Company Details

Table RxBio, Inc. Company Details

Table Soligenix, Inc. Company Details

Table Global Choroidal Neovascularization Drug Sales Forecast by Regions 2019-2025 (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Market Share Forecast by Regions 2019-2025

Table Global Choroidal Neovascularization Drug Revenue Forecast by Regions 2019-2025 (Million US$)

Table Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Regions 2019-2025

Table Global Choroidal Neovascularization Drug Sales Forecast by Product 2019-2025 (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Market Share Forecast by Product 2019-2025

Table Global Choroidal Neovascularization Drug Revenue Forecast by Product 2019-2025 (Million US$)

Table Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Product 2019-2025

Table Global Choroidal Neovascularization Drug Sales Forecast by End User 2019-2025 (K Pcs)

Table Global Choroidal Neovascularization Drug Sales Market Share Forecast by End User 2019-2025

Figure North America Choroidal Neovascularization Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)

Figure North America Choroidal Neovascularization Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Europe Choroidal Neovascularization Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)

Figure Europe Choroidal Neovascularization Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Asia Pacific Choroidal Neovascularization Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)

Figure Asia Pacific Choroidal Neovascularization Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Central & South America Choroidal Neovascularization Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)

Figure Central & South America Choroidal Neovascularization Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)

Figure Middle East and Africa Choroidal Neovascularization Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)

Figure Middle East and Africa Choroidal Neovascularization Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)

Table Choroidal Neovascularization Drug Value Chain

Table Choroidal Neovascularization Drug Customers List

Table Choroidal Neovascularization Drug Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.